In the U.S. about 6.7 million people have Alzheimer’s, making it the seventh leading cause of death in the country. It’s also the most common cause of dementia among older adults. In July, the FDA approved a new drug that helps slow down the rate of memory loss. Dr. Sanjeev Vaishnavi is an assistant professor of neurology at the University of Pennsylvania Perelman School of Medicine and the Clinical Director of the Division of Cognitive Neurology. He tells us more about the new drug, some of the challenges of curing Alzheimer’s and what this new drug might mean for the future of Alzheimer’s research. 

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices